Lisdexamfetamine dimesylate, an active component of Vyvanse, is a prescription drug. Attention deficit hyperactivity disorder (ADHD) and binge eating disorder (BED) are the two conditions it is most commonly used to treat.

Vyvanse is a central nervous system stimulant that alters specific brain and nerve molecules. It functions by raising dopamine and norepinephrine levels in the brain, which aids in enhancing attention, focus, and impulse control in those with ADHD.

Vyvanse is typically taken in the morning once day for the treatment of ADHD. Based on the patient's needs and pharmaceutical reaction, a healthcare practitioner decides on the dosage and length of the course of therapy.

Adults with moderate to severe binge eating disorders (BED) may use Vyvanse, which is also licensed for this purpose.